Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of SYN010 HFA vs Symbicort in Healthy Volunteers
NCT02850484Phase 1Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Mar 2016
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of budesonide + formoterol in asthma and chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Intech Biopharm Corporation. Primary endpoints: Area Under Curve and Maximum plasma concentration. Started Mar 2016; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02850484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850484.